【参考文献】
  1 Warejcka DJ, Vaughan KA, Bernstein AM, Twining SS. Differntial conversion of plasminogen to angiostatin by human corneal cell populations. Mol Vis ,2005;11:859-868

2 Zhang P, Wu D, Ge J, Zhu Z, Feng G, Yue T, Lin J, Zheng H. Experimental inhibition of corneal neovascularization by endostatin gene trasfection in vivo. Chin Med J(Engl) ,2003;116(12):1869-1874

3 Feng Y, Feng Y, Liao X, Zhu X, Zhou Q, Zeng Z, Ma Q. Inhibition of corneal neovascularization by liposomes mediated plasmid encoding human endostatin. Chin J Ophthalmol ,2005;41(1):260-264

4 Wu PC, Yang LC, Kuo HK, Huang CC, Tsai CL, Lin PR, Wu PC, Shin SJ, Tai MH. Inhibition of corneal angiogenesis by local application of vasostatin. Mol Vis ,2005;11:28-35

5 Yoon KC, Ahn KY, Lee JH, Chun BJ, Park SW, Seo MS, Park YG, Kim KK. Lipid-mediated delivery of brain-specific angiogenesis inhibitor 1 gene reduces corneal neovascularization in an in vivo rabbit model. Gene Ther , 2005;12(7):617-624

6 Berdugo M, Andrieu-Soler C, Doat M, Courtois Y, Benezra D, Behar-Cohen F. Downregulation of IRS-1 Expression Causes Inhibition of Corneal Angiogenesis. Invest Ophthalmol Vis Sci ,2005;46(11):4072-4078

7 Sarayba MA, Li L, Tungsiripat T, Liu NH, Sweet PM, Patel AJ, Osann KE, Chittiboyina A, Benson SC, Pershadsingh HA, Chuck RS. Inhibition of corneal neovascularization by a peroxisome proliferators-activated receptor-gamma ligand. Exp Eye Res ,2005;80(3):435-442

8 Biswas PS, Banerjee K, Kim B, Kinchington PR, Rouse BT. Role of inflammatory cytokine-induced cyclooxygenase 2 in the ocular immunopathologic disease herpetic stromal keratitis. J Virol ,2005;79(16):10589-10600

9 Lai CM, Brankov M, Zaknich T, Lai YK, Shen WY, Constable IJ, Kovesdi I, Rakoczy PE. Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization. Hum Gene Ther ,2001;12(10):1299-1310

10 Singh N, Amin S, Richter E, Rashid S, Scoglietti V, Jani PD, Wang J, Kaur R, Ambati J, Dong Z, Ambati BK. Flt-1 intraceptors inhibit hypoxia-induced VEGF expression in vitro and corneal neovascularization in vivo. Invest Ophthalmol Vis Sci ,2005;46(5):1647-1652

11 Singh N, Macnamara E, Rashid S, Ambati J, Kontos CD, Higgins E, Ambati BK. Systemic soluble Tie2 expression inhibits and regresses corneal neovascularization. Biochem Biophys Res Commun ,2005;332(1):194-199

12 Heying Zhang, Chen Li and Peter C. Baciu. Expression of integrins and MMPs during alkaline-burn-induced corneal angiogenesis. Invest Ophthalmol Vis Sci ,2002;43(4):955-962

13 Klotz O, Park JK, Pleyer U, Hartmann C, Baatz H. Inhibition of corneal neovascularization by alpha(v)-integrin antagonists in the rat. Graefes Arch Clin Exp Ophthalmol ,2000;238(1):88-93

14 Samolov B, Steen B, Seregard S, van der Ploeg I, Montan P, Kvanta A. Delayed inflammation-associated corneal neovascularization in MMP-2-deficient mice. Exp Eye Res ,2005;80(2):159-166

15 Ma DH, Zhang F, Shi W, Yao JY, Hsiao CH, Wu HC, Kim WS, Hao YX, Hwang DG, Chen JK, Tsai RJ. Expression of tissue inhibitor of metalloproteinase-4 in normal human corneal cells and experimental corneal neovascularization. Ophthalmic Res ,2003;35(4):199-207

16 Ma X, Bazan H, Li J. Suppression of corneal neovascularization by conditioned culture medium of human amniotic membrane. Chin J Ophthalmol ,2003;39(12):753-756

17 Yu WZ, Li XX, She HC, He PY, Dong JQ, Rui M, Ma DL. Gene transfer of kringle 5 of plasminogen by electroporation inhibits corneal neovascularization. Ophthalmic Res ,2003;35(5):239-246

18 Kim B, Tang Q, Biswas PS, Xu J, Schiffelers RM, Xie FY, Ansari AM, Scaria PV, Woodle MC, Lu P, Rouse BT. Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis. Am J Pathol ,2004;165(6):2177-2185

19 Xu JH, Zhang H, Liu ZL, Li RX, Kong W, Zhang W. Effect of triamcinolone acetonide and vascular endothelial growth factor in a mouse model of retinal neovascularization. Int J Ophthalmol(Guoji Yanke Zazhi) ,2006;6(3):587-590

20 Wang LL, Zhu ZQ, Wang Y, Wang HY. Effects of intravitreal administration of triamcinolone acetonide on postoperative proliferative vitreoretinopathy. Int J Ophthalmol(Guoji Yanke Zazhi) ,2005;5(4):685-687

21 Kreissig I, Jonas JB, Vossmerbaeumer U. Triamcinolone Acetonide: Preparation for Intravitreal Injection. Int J Ophthalmol(Guoji Yanke Zazhi) ,2005;5(5):881-883

22 Zhang YB, Cheng XL, Dong J. Treatment of diabetic macular edema by dual intravitreal injections of triamcinolone. Int J Ophthalmol(Guoji Yanke Zazhi) ,2005;5(6):1207-1210

23 Murata M, Shimizu S, Horiuchi S, Taira M.Inhibitory effect of triamcinolone acetonide on corneal neovascularization. Graefes Arch Clin Exp Ophthalmol ,2005;26:1-5

24 Li B, Hong J, Zhao LY, Wei J.Experimental studies of rapamycin eye drops on the prevention of penetrating keratoplasty rejection in a rat model. Int J Ophthalmol(Guoji Yanke Zazhi) ,2006;6(3):591-593

25 Kwon YS, Hong HS, Kim JC, Shin JS, Son Y.Inhibitory effect of rapamycin on corneal neovascularization in vitro and in vivo. Invest Ophthalmol Vis Sci ,2005;46(2):454-460

26 Fossarello M, Peiretti E, Zucca I, Serra A. Photodynamic therapy of corneal neovascularization with verteporfin. Cornea ,2003;22:485-488

27 Usui T, Sugisaki K, Amano S, Jang WD, Nishiyama N, Kataoka K.New Drug Delivery for Corneal Neovascularization Using Polyion Complex Micelles. Cornea ,2005;24(8 Suppl 1):39-42

上一页  [1] [2] [3] [4] [5]